What it sells
HeartWatch, a medical-grade, non-adhesive dry-electrode ambulatory ECG arm monitor worn for months to detect cardiac arrhythmias.
Business model breakdown
Buyer: who owns the budget?
Cardiologists and physicians ordering ambulatory ECG monitoring; payors are also referenced ("best economic value for patients and payors").
Trigger: what makes them buy now?
Short-term Holter/MCT patch monitors (15-30 days) cause skin irritation and miss transient arrhythmias, while implantable loop recorders are invasive and costly (cryptogenic stroke, syncope).
Workflow: what inputs become what output?
Patient wears the arm monitor and logs symptoms in the HeartWatch app; a certified cardiac technician reviews the recording and a report goes to the physician to guide treatment.
Distribution: how it reaches customers
Physician-prescribed device; currently an investigational device not for sale in the US, with Canada-based contact line.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2017 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.